bpc-157 not approved for human use fda warning WATCH: advisory panel narrowly backs of several peptides favored by RFK Jr An FDA advisory panel will
An FDA advisory panel will spend the next two days discussing whether compounding pharmacies can fill prescriptions for some unapproved peptides. The meeting comes amid a surge of interest in the unapproved FDA reviews BPC 157, TB 500 and other peptides favored by RFK Jr. WSB TV Channel 2 Atlanta Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers
Pay in 4 interest-free payments of $7.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
